Abstract
The occurrence of treatment failures to first-line treatment for giardiasis, one of the most widespread although neglected parasitic disease, has long been recognised. Nowadays, it starts to represent a great challenge to clinicians, especially in endemic countries. This requires the introduction of new drug interventions, but the development of novel drugs is a time and money consuming effort with most of the compounds never reaching the market. Consequently, alternative strategies are needed, especially for the treatment of giardiasis. Chloroquine (CQ), a synthetic drug developed as antimalarial agent, has been shown to also exert antigiardial activity. Here, we present a mini-research summarizing results on the treatment of human clinical cases with CQ, going through in vitro research, case report, and case series to human clinical trials, highlighting the benefits and mentioning possible adverse effects.
Keywords: Chloroquine, Giardia, treatment.
Graphical Abstract
Recent Patents on Anti-Infective Drug Discovery
Title:Chloroquine: An Old Drug with New Perspective Against Giardiasis
Volume: 10 Issue: 2
Author(s): Angel A. Escobedo, Pedro Almirall, Sérgio Cimerman, Marco Lalle, Frank Pacheco, Carlos Z. Acanda and Niurka Sánchez
Affiliation:
Keywords: Chloroquine, Giardia, treatment.
Abstract: The occurrence of treatment failures to first-line treatment for giardiasis, one of the most widespread although neglected parasitic disease, has long been recognised. Nowadays, it starts to represent a great challenge to clinicians, especially in endemic countries. This requires the introduction of new drug interventions, but the development of novel drugs is a time and money consuming effort with most of the compounds never reaching the market. Consequently, alternative strategies are needed, especially for the treatment of giardiasis. Chloroquine (CQ), a synthetic drug developed as antimalarial agent, has been shown to also exert antigiardial activity. Here, we present a mini-research summarizing results on the treatment of human clinical cases with CQ, going through in vitro research, case report, and case series to human clinical trials, highlighting the benefits and mentioning possible adverse effects.
Export Options
About this article
Cite this article as:
Escobedo A. Angel, Almirall Pedro, Cimerman Sérgio, Lalle Marco, Pacheco Frank, Acanda Z. Carlos and Sánchez Niurka, Chloroquine: An Old Drug with New Perspective Against Giardiasis, Recent Patents on Anti-Infective Drug Discovery 2015; 10 (2) . https://dx.doi.org/10.2174/1574891X10666150914122118
DOI https://dx.doi.org/10.2174/1574891X10666150914122118 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
The Involvement of Metallothioneins in Mitochondrial Function and Disease
Current Protein & Peptide Science Role of Copper in Prion Diseases: Deleterious or Beneficial?
Current Pharmaceutical Design HIV-1 Replication from After Cell Entry to the Nuclear Periphery
Current HIV Research The Many Faces of Aβ: Structures and Activity
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Fospropofol, A New Sedative Anesthetic, and Its Utility in the Perioperative Period
Current Pharmaceutical Design Inflammation and Thrombophilia in Pregnancy Complications: Implications for Risk Assessment and Clinical Management
Cardiovascular & Hematological Disorders-Drug Targets Recent Patents in Cartilage Regeneration
Recent Patents on Regenerative Medicine Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses
Current Pharmaceutical Design Pulmonary Surfactant Proteins A and D: Innate Immune Functions and Biomarkers for Lung Diseases
Current Pharmaceutical Design The Role of Lymphotoxin Receptor Signaling in Diseases
Current Molecular Medicine Cellular Therapy for Heart Failure
Current Cardiology Reviews Lipidomics as Tools for Finding Biomarkers of Intestinal Pathology: From Irritable Bowel Syndrome to Colorectal Cancer
Current Drug Targets Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis
Current Pharmaceutical Design Accuracy and Reproducibility of Stem Cell Side Population Measurements on Clinically Relevant Products
Current Stem Cell Research & Therapy Substituted 1,2,4-oxodiazoles as Potent Inhibitors of Human 11β - hydroxysteroid Dehydrogenase Type 1 (11β-HSD1): Virtual Screening and Docking Results
Letters in Drug Design & Discovery The Tangled Mitochondrial Metabolism in Cancer: An Innovative Pharmacological Approach
Current Medicinal Chemistry